Who Owns MBRX?

Moleculin Biotech, Inc. — Institutional Ownership & 13F Holdings

$2.54

+0.00 (+0.00%)

Market Cap

$2.6M

Shares Outstanding

1,209,120

Institutional Holders

23

Total Inst. Value

$1.4M

% of Float Held

124.9%

QoQ Holder Change

+6

Institutional data as of Q1 2025

New Positions

7

Closed Positions

4

Increased

5

Decreased

2

Institutional Ownership Trend

Top 10 Institutional Holders(Q1 2025)

#FundValueShares
1ARMISTICE CAPITAL, LLC$1.2M1,250,000
2Cetera Investment AdvisersNew$68K70,000
3LPL Financial LLC$45K46,080
4VANGUARD GROUP INC$29K30,935
5GEODE CAPITAL MANAGEMENT, LLC$25K26,057
6BlackRock, Inc.$12K12,380
7Cambridge Investment Research Advisors, Inc.New$12K12,781
8XTX Topco LtdNew$11K11,575
9TRUIST FINANCIAL CORP$10K10,500
10CITIGROUP INCNew$3K2,788

Biggest Buyers & Sellers This Quarter

Related Stocks

Frequently Asked Questions

How many institutional investors hold MBRX?

As of Q1 2025, 23 institutional investors report holding MBRX (Moleculin Biotech, Inc.) in their 13F filings.

What percentage of Moleculin Biotech, Inc. is owned by institutions?

Institutional investors hold approximately 124.9% of Moleculin Biotech, Inc.'s float as reported in SEC 13F filings.

Which hedge fund owns the most MBRX?

The largest institutional holder of MBRX is ARMISTICE CAPITAL, LLC with $1.2M in shares.

Are institutions buying or selling MBRX?

This quarter, 7 institutions opened new positions in MBRX and 4 closed their positions.

What is 13F institutional ownership?

SEC Form 13F is a quarterly report filed by institutional investment managers with over $100M in qualifying assets. It discloses their US equity holdings, providing transparency into what the largest investors are buying and selling.

How often is institutional ownership data updated?

13F filings are due 45 days after each calendar quarter end (May 15, Aug 14, Nov 14, Feb 14). Data is updated on HedgeTrace as new filings are processed.